Seeking AlphaCodex · 实盘不做把握 2/10
北京时间·🕒 发布 05:35:26时区推断·⟳ 抓取 05:35:51·⚡ 决策 07-23 06:05:01 +29m10s·96.5 天前
Summit Therapeutics 将于7月23日盘后发布二季度业绩，当前仅为业绩预告日程提醒
该信号只是 Seeking Alpha 的财报发布时间和一致预期汇总，未披露实际业绩、指引或超预期增量。
📄 原文Seeking Alpha↗ 原文
Summit Therapeutics Q2 2026 Earnings Preview
- Summit Therapeutics (SMMT) is scheduled to announce Q2 earnings results on Thursday, July 23, after market close. - T…
不做 Summit Therapeutics（SMMT.US）
仅为财报预告和一致预期汇总，未披露实际结果、指引或超预期信息，当前无同向交易 edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-22 · 扩散 medium · price-in 风险 high ↗
关键理由
- 该信号只是 Seeking Alpha 的财报发布时间和一致预期汇总，未披露实际业绩、指引或超预期增量。
主要风险
- 若7月23日盘后正式财报出现显著超预期或指引变化，应由新信号重新研判。
原文全文
展开原文 · 437 字
- Summit Therapeutics (SMMT) is scheduled to announce Q2 earnings results on Thursday, July 23, after market close.
- The consensus EPS estimate is -$0.29 (-141.7% Y/Y).
- Over the last 2 years, SMMT has beaten EPS estimates 38% of the time and has beaten revenue estimates 0% of the time.
- Over the last 3 months, EPS estimates have seen 9 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
- The consensus EPS estimate is -$0.29 (-141.7% Y/Y).
- Over the last 2 years, SMMT has beaten EPS estimates 38% of the time and has beaten revenue estimates 0% of the time.
- Over the last 3 months, EPS estimates have seen 9 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。